Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 639Head and Neck Neoplasms 613Carcinoma, Non-Small-Cell Lung 203Thyroid Neoplasms 201Melanoma 146Nasopharyngeal Carcinoma 136Oropharyngeal Neoplasms 130Colorectal Neoplasms 130Mouth Neoplasms 128Neoplasms 113Breast Neoplasms 113Lung Neoplasms 107Ovarian Neoplasms 105Uterine Cervical Neoplasms 101Neoplasm Metastasis 93Carcinoma, Squamous Cell 87Stomach Neoplasms 84Carcinoma, Renal Cell 84Triple Negative Breast Neoplasms 79Pancreatic Neoplasms 72Esophageal Neoplasms 70Laryngeal Neoplasms 68Endometrial Neoplasms 67Urinary Bladder Neoplasms 61Sarcoma 58Prostatic Neoplasms 55Thyroid Cancer, Papillary 54Salivary Gland Neoplasms 49Carcinoma, Transitional Cell 47Carcinoma, Hepatocellular 46

Interventions

toripalimab 1Radiotherapy 1Docetaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × Head & Neck × 1 year × Clear all
NCT06940180 2025-06-26

Toripalimab With Chemotherapy for Sinus Cancer

Dana-Farber Cancer Institute

Phase 2 Recruiting
20 enrolled
Head & Neck

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡